摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,8-dichloro-7-methyl-2-(trifluoromethyl)-2H-1-benzopyran-3-carboxylic acid | 215122-17-1

中文名称
——
中文别名
——
英文名称
6,8-dichloro-7-methyl-2-(trifluoromethyl)-2H-1-benzopyran-3-carboxylic acid
英文别名
6,8-dichloro-7-methyl-2-(trifluoromethyl)-2H-chromene-3-carboxylic acid
6,8-dichloro-7-methyl-2-(trifluoromethyl)-2H-1-benzopyran-3-carboxylic acid化学式
CAS
215122-17-1
化学式
C12H7Cl2F3O3
mdl
——
分子量
327.087
InChiKey
PISILYOCQRGSBP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    20
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    ethyl 6,8-dichloro-7-methyl-2-(trifluoromethyl)-2H-1-benzopyran-3-carboxylate 、 sodium hydroxidewater ethanol 作用下, 以 四氢呋喃乙醇 为溶剂, 反应 3.5h, 以to yield a yellow solid (6.0 g, 78%)的产率得到6,8-dichloro-7-methyl-2-(trifluoromethyl)-2H-1-benzopyran-3-carboxylic acid
    参考文献:
    名称:
    Substituted benzopyran derivatives for the treatment of inflammation
    摘要:
    一类苯并吡喃衍生物被描述为用于治疗环氧合酶-2介导的疾病。特别感兴趣的化合物由公式I'定义,其中X,A1,A2,A3,A4,R,R",R1和R2如规范中所述。
    公开号:
    US20050049252A1
点击查看最新优质反应信息

文献信息

  • Antiangiogenic combination therapy for the treatment of cancer
    申请人:——
    公开号:US20020103141A1
    公开(公告)日:2002-08-01
    The present invention provides combinations of a DNA topoisomerase I inhibiting agent and a selective COX-2 inhibiting agent for preventing, treating, and/or reducing the risk of developing a neoplasia disorder in a mammal.
    本发明提供了一种DNA拓扑异构酶I抑制剂和选择性COX-2抑制剂的组合物,用于预防、治疗和/或减少哺乳动物发生肿瘤性疾病的风险。
  • Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
    申请人:Pulaski P. Steven
    公开号:US20050014729A1
    公开(公告)日:2005-01-20
    A method for preventing or treating dermatological disorders and dermatological disorder-related complications in a subject involves a monotherapy with a Cox-2 inhibitor or a combination therapy with a Cox-2 inhibitor and a dermatological treatment agent. Also described are therapeutic compositions comprising a Cox-2 inhibitor and a dermatological treatment agent. Pharmaceutical compositions and kits for implementing the present method are also described.
    一种预防或治疗受试者的皮肤病和与皮肤病相关并发症的方法涉及使用Cox-2抑制剂进行单独治疗或与Cox-2抑制剂和皮肤治疗剂的联合治疗。还描述了包含Cox-2抑制剂和皮肤治疗剂的治疗组合物。还描述了用于实施本方法的药物组合物和工具包。
  • [EN] METHOD FOR PREVENTING OR TREATING AN OPTIC NEUROPATHY<br/>[FR] METHODE PERMETTANT DE PREVENIR OU DE TRAITER UNE NEUROPATHIE OPTIQUE
    申请人:PHARMACIA CORP
    公开号:WO2005021004A1
    公开(公告)日:2005-03-10
    The present invention provides methods and compositions for the prevention and/or treatment of an optic neuropathy, comprising a Cox-2 inhibitor and an intraocular pressure reducing agent.
    本发明提供了一种预防和/或治疗视神经病变的方法和组合物,包括Cox-2抑制剂和降低眼压的药剂。
  • Treatment and prevention of otic disorders with Cox-2 inhibitors alone or in combination with otic agents
    申请人:Pharmacia Corporation
    公开号:US20040204471A1
    公开(公告)日:2004-10-14
    A method for preventing or treating otic disorders and otic disorder-related complications in a subject involves a monotherapy with a Cox-2 inhibitor or a combination therapy with a Cox-2 inhibitor and an otic agent. Also described are therapeutic compositions comprising a Cox-2 inhibitor and an otic agent. Pharmaceutical compositions and kits for implementing the present method are also described.
    一种用于预防或治疗主体的耳部疾病和耳部疾病相关并发症的方法涉及使用Cox-2抑制剂进行单一疗法或使用Cox-2抑制剂和耳部药剂进行联合疗法。还描述了包含Cox-2抑制剂和耳部药剂的治疗组合物。还描述了用于实施本方法的药物组合物和工具包。
  • Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith
    申请人:Pharmacia Corporation
    公开号:US20040220155A1
    公开(公告)日:2004-11-04
    A method is described for providing a steroid-sparing benefit to a subject that is in need of, or that is presently receiving, a corticosteroid, the method comprising administering to the subject a cyclooxygenase-2 inhibitor in combination with a corticosteroid. Therapeutic compositions, pharmaceutical compositions and kits that are useful for implementing the present method are also described.
    描述了一种为需要或目前正在接受皮质类固醇治疗的受试者提供节约类固醇的方法,该方法包括向受试者同时给予环氧合酶-2抑制剂和皮质类固醇。还描述了用于实施该方法的治疗组合物、药物组合物和工具包。
查看更多